These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2475149)

  • 1. Human monoclonal antibodies with a protective activity against tetanus toxin.
    Trabaud MA; Lery L; Desgranges C
    APMIS; 1989 Aug; 97(8):671-6. PubMed ID: 2475149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against tetanus toxin and toxoid.
    Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E
    Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C.
    Gustafsson B; Whitmore E; Tiru M
    Hybridoma; 1993 Dec; 12(6):699-708. PubMed ID: 8288271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule.
    Ziegler-Heitbrock HW; Reiter C; Trenkmann J; Fütterer A; Riethmüller G
    Hybridoma; 1986; 5(1):21-31. PubMed ID: 2420699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.
    Volk WA; Bizzini B; Snyder RM; Bernhard E; Wagner RR
    Infect Immun; 1984 Sep; 45(3):604-9. PubMed ID: 6205994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.
    Matsuda M; Kamei M; Sugimoto N; Ma Y; Hashizume S
    Eur J Epidemiol; 1992 Jan; 8(1):1-8. PubMed ID: 1572415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective murine monoclonal antibodies to tetanus toxin.
    Shang HF; Liau MY; Chow MF; Jiang SY; Chen SC; Yeh MY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):199-209. PubMed ID: 3151481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective human hybridoma antibody to tetanus toxin.
    Gigliotti F; Insel RA
    J Clin Invest; 1982 Dec; 70(6):1306-9. PubMed ID: 7174795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of monoclonal antibodies to tetanus toxin.
    Sheppard AJ; Cussell D; Hughes M
    Infect Immun; 1984 Feb; 43(2):710-4. PubMed ID: 6198285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lymphoblastoid cell line producing protective monoclonal IgG1, kappa anti-tetanus toxin.
    Tiebout RF; Stricker EA; Hagenaars R; Zeijlemaker WP
    Eur J Immunol; 1984 May; 14(5):399-404. PubMed ID: 6327321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
    Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
    Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design.
    Luo P; Qin L; Mao X; Chen L; Yu S; Li Q; Liu W; Zhang W; Gu J; Zou Q
    Vaccine; 2012 Oct; 30(45):6449-55. PubMed ID: 22889825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tetanus toxoid antibody production and protection against lethal doses of tetanus toxin in hu-PBL-SCID mice.
    Naito S; Okada Y; Takahashi M; Kato H; Taneichi M; Ami Y; Suzaki Y; Oka T; Okuma K; Morokuma K; Onodera H; Inoue M; Takahashi Y; Yamazaki S; Kimura H; Komuro K; Uchida T
    Int Arch Allergy Immunol; 2000 Oct; 123(2):149-54. PubMed ID: 11060487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of neutralizing human monoclonal antibody directed to tetanus toxin in CHO cell.
    Chin J; Sohn Y; Lee SH; Park YI; Choi MJ
    Biologicals; 2003 Mar; 31(1):45-53. PubMed ID: 12623059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptide antigens of tetanus toxin.
    Fischer PM; Howden ME
    Mol Immunol; 1994 Oct; 31(15):1141-8. PubMed ID: 7935502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.
    Simpson LL; Lake P; Kozaki S
    J Pharmacol Exp Ther; 1990 Jul; 254(1):98-103. PubMed ID: 1694896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies as probes of tetanus toxin structure and function.
    Kenimer JG; Habig WH; Hardegree MC
    Infect Immun; 1983 Dec; 42(3):942-8. PubMed ID: 6642671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.
    Chin LT; Hinkula J; Levi M; Ohlin M; Wahren B; Borrebaeck CA
    Immunology; 1994 Mar; 81(3):428-34. PubMed ID: 7515847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.